MedPath

Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy

Completed
Conditions
C.Medical Procedure; Digestive System
Disorder of Upper Gastrointestinal Tract
Tolerance
Interventions
Drug: Case Group
Registration Number
NCT02307773
Lead Sponsor
Cheju Halla General Hospital
Brief Summary

The investigators tested whether a new method which additional lidocaine spray on the tip of endoscope can increase the tolerance of examinee during endoscopy than conventional pharyngeal anesthesia alone.

Detailed Description

All the patients underwent upper gastrointestinal endoscopy were consecutively enrolled and assigned to case group treated with additional 2 puffs of the 10% lidocaine spray on the tip of endoscope before intubation or control group with conventional pharyngeal anesthesia without further treatment. And the investigators compared their baseline characteristics, past history, sedation or not, and frequency of retching and belching were measured during the endoscopy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
497
Inclusion Criteria
  • All the patients who underwent upper gastrointestinal endoscopy in Endoscopy Room, Cheju Hall General Hospital.
Exclusion Criteria
  • advanced older or younger age (> 90, or < 15 years)
  • comorbidities scored greater than III of American Society of Anestheiologists Physical Status Classification System (ASA) score
  • history of hypersensitivity reaction to lidocaine
  • he pregnant
  • therapeutic or emergency endoscopy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Case GroupCase GroupTreated with additional 2 puffs of the 10% lidocaine spray on the tip of endoscope before intubation with conventional pharyngeal anesthesia
Primary Outcome Measures
NameTimeMethod
Frequency of Belching and retchingParticipants will be followed for the duration of hospital stay, expected average of 1-2 hours

Belching was defined as release of gas from the digestive tract (mainly esophagus and stomach) through the mouth and retching was defined as reverse peristaltic movement of the stomach and esophagus without vomiting.

Secondary Outcome Measures
NameTimeMethod
Adverse eventsParticipants will be followed for the duration of hospital stay, expected average of 1-2 hours

Events suspected as Aspiration pneumonia, methemoglobinemia

Trial Locations

Locations (1)

Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital

🇰🇷

Jeju-si, Jeju Special Self-Governing Province, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath